Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).
about
Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.Treatment of osteoporosis: current and future.Clinical experience with pamidronate in the treatment of Paget's disease of bone.Paget's disease of bone treated with a five day course of oral tiludronate.Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.Drug treatment of primary hyperparathyroidism: use of clodronate disodium.Pamidronate.Preventive effects of zoledronic acid on bone metastasis in mice injected with human breast cancer cells.What is the relationship between Paget's disease of bone and hyperparathyroidism?Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronateDifferential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.Current options for the treatment of Paget's disease of the bone.Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies.Pharmacotherapy of Paget's disease of bone.Control of osteitis deformans using glucagon, calcitonin, and mithramycinRadiological assessment of Paget's disease of bone after treatment with the bisphosphonates EHDP and APD.Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration.Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.Treatment of Paget's disease of bone with aminohydroxybutylidene bisphosphonate.Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.Side effects of disodium aminohydroxypropylidenediphosphonate (APD) during treatment of bone diseases.Long-Term Effects of Intravenous Ibandronate in Paget's Disease of Bone.Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline.Zoledronate: efficacy and safety.Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy
P2860
Q33557119-CF42FEDF-87CC-474E-A37A-C1DF624FA949Q33563886-9E1B13F4-A317-46FF-BB03-4129CDC14E45Q33564104-87CA1936-4D70-4B97-BF2A-B56F607C83DFQ33565205-8B47F6C4-5705-4697-8261-574D4C58EFBEQ34018048-D9BBA7CF-DF73-4785-9A1F-CB4C844B7A42Q34073206-511DBFBF-555A-4627-902C-CFD8AB30C226Q34216753-A714A9D7-CC68-4ADB-B85E-93887DD02EAFQ34990871-DEF9E32D-2C4D-4533-8D1A-8CB7A36BB7C0Q35466455-0331AFF2-0F52-4893-9C6F-F4986F1E9C3CQ35590612-7AD10642-9D9E-4B95-BEF2-3A5594F1A8A2Q36710175-89FC747A-14DB-4910-A776-BC315F74E2A9Q36724013-E78F40A0-4B55-4028-8174-35AF234B86B1Q36987389-2C5DA9ED-2977-4170-A73E-CD37FE6B27A8Q37358122-2469B892-C8E4-4F10-BA6A-A5C354A73430Q37918967-406958D1-DDBA-4436-9AE3-F670A563FE6DQ37984490-C23543CE-E762-48DD-B0BF-AA931EA06704Q39065094-828C0027-83D7-4E94-858E-A1EDDDA7433FQ39536499-CF4DA9E5-70E9-4AEB-8DD7-4426856669F9Q40310722-9461DBDF-E183-428B-92AA-B220D877EF3DQ40379763-040072E9-9D5D-489B-A30D-6D8FF4BED015Q40762702-7F120BCB-0665-4864-9D75-B11E5A45731AQ40846743-36111F6F-CA19-4B2E-ACD0-54A3B5079C63Q41145217-98E153CF-F60A-47C7-9678-49AC4EB37737Q42069297-1348D7D9-D03C-40B8-BA9E-40C934275EBFQ48212868-BB8CF132-D0B6-49E6-80CC-D5987885F4B8Q53033362-E1F6E86B-FBF2-4A99-9F6D-D4FDABB2B5B9Q53209081-6C4EFD8F-B257-470D-A0EA-BC0139DA6D9AQ57104134-EBD32A43-CF6E-4C60-BBDE-9A7882B4808D
P2860
Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Treatment of Paget's disease w ...... -1, 1-bisphosphonate (A.P.D.).
@en
Treatment of Paget's disease w ...... -1, 1-bisphosphonate (A.P.D.).
@nl
type
label
Treatment of Paget's disease w ...... -1, 1-bisphosphonate (A.P.D.).
@en
Treatment of Paget's disease w ...... -1, 1-bisphosphonate (A.P.D.).
@nl
prefLabel
Treatment of Paget's disease w ...... -1, 1-bisphosphonate (A.P.D.).
@en
Treatment of Paget's disease w ...... -1, 1-bisphosphonate (A.P.D.).
@nl
P2093
P1433
P1476
Treatment of Paget's disease w ...... -1, 1-bisphosphonate (A.P.D.).
@en
P2093
J te Velde
O L Bijvoet
W B Frijlink
P304
P356
10.1016/S0140-6736(79)91318-7
P407
P577
1979-04-01T00:00:00Z